Chowdhury Tahseen A
Department of Diabetes and Metabolism, The Royal London Hospital, London E1 1BB, United Kingdom.
World J Diabetes. 2021 Mar 15;12(3):198-205. doi: 10.4239/wjd.v12.i3.198.
Diabetes and coronavirus disease 2019 (COVID-19) are worldwide pandemics that have had a major impact on public health throughout the globe. Risk factors for developing diabetes and having adverse outcomes of COVID-19 appear to be similar; metabolic factors (such as obesity), non-White ethnicity and poorer socioeconomic status appear to be risk factors for both. Diabetes and COVID-19 have a significant effect on populations adversely affected by health inequality. Whilst we hope that COVID-19 will be mitigated by widespread use of vaccines, no such prospect exists for mitigating the pandemic of diabetes. In this brief opinion review, I compare risk factors for diabetes and adverse outcomes of COVID-19 and argue that tackling health and social inequality is likely to play a major role in solving the global diabetes pandemic and improve outcomes of COVID-19.
糖尿病和2019冠状病毒病（COVID-19）是全球性大流行病，对全球公共卫生产生了重大影响。患糖尿病的风险因素以及COVID-19的不良后果似乎相似；代谢因素（如肥胖）、非白人种族和较差的社会经济地位似乎都是两者的风险因素。糖尿病和COVID-19对受健康不平等不利影响的人群有重大影响。虽然我们希望通过广泛接种疫苗来缓解COVID-19，但对于缓解糖尿病大流行却没有这样的前景。在这篇简短的观点综述中，我比较了糖尿病的风险因素和COVID-19的不良后果，并认为解决健康和社会不平等问题可能在解决全球糖尿病大流行以及改善COVID-19的结果方面发挥重要作用。
